These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36455536)

  • 1. The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review.
    Lu Y; Zhong E; Wu J; Cao Y
    Ophthalmic Res; 2023; 66(1):431-444. PubMed ID: 36455536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostaglandin analogues on central corneal thickness in patients with glaucoma: A systematic review and meta-analysis with trial sequential analysis.
    Kadri R; Shetty A; Parameshwar D; Kudva AA; Achar A; Shetty J
    Indian J Ophthalmol; 2022 May; 70(5):1502-1512. PubMed ID: 35502015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review.
    Ruiz-Lozano RE; Alamillo-Velazquez J; Ortiz-Morales G; Garza-Garza LA; Quiroga-Garza ME; Alvarez-Guzman C; Rodriguez-Garcia A
    Int Ophthalmol; 2023 Feb; 43(2):677-695. PubMed ID: 35962295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in central corneal thickness over time: the ocular hypertension treatment study.
    Brandt JD; Gordon MO; Beiser JA; Lin SC; Alexander MY; Kass MA;
    Ophthalmology; 2008 Sep; 115(9):1550-6, 1556.e1. PubMed ID: 18378313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes.
    Tsikripis P; Papaconstantinou D; Koutsandrea C; Apostolopoulos M; Georgalas I
    Drug Des Devel Ther; 2013; 7():1149-56. PubMed ID: 24115838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostaglandin analogues and central corneal thickness].
    Stefan C; Dumitrica DM; Tebeanu E; Nae I; Sapundgieva A; Dragomir L
    Oftalmologia; 2007; 51(4):95-9. PubMed ID: 18543683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Biomechanically Corrected Intraocular Pressure Obtained by Corvis ST and Goldmann Applanation Tonometry in Patients With Open-angle Glaucoma and Ocular Hypertension.
    Ye Y; Yang Y; Fan Y; Lan M; Yu K; Yu M
    J Glaucoma; 2019 Oct; 28(10):922-928. PubMed ID: 31453898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma.
    Harasymowycz PJ; Papamatheakis DG; Ennis M; Brady M; Gordon KD;
    Cornea; 2007 Jan; 26(1):34-41. PubMed ID: 17198011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma.
    Meda R; Wang Q; Paoloni D; Harasymowycz P; Brunette I
    Br J Ophthalmol; 2017 Feb; 101(2):120-125. PubMed ID: 27162226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    DI Staso S; Agnifili L; Cecannecchia S; DI Gregorio A; Ciancaglini M
    In Vivo; 2018; 32(2):211-220. PubMed ID: 29475902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Central thickness of the cornea in ocular hypertension and open-angle glaucoma].
    Chiseliţă D; Danielescu C; Gagos-Zaharia O; Gherman C
    Oftalmologia; 2007; 51(3):98-103. PubMed ID: 18064964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of central corneal thickness on response to topical prostaglandin analogue therapy.
    Birt CM; Buys YM; Kiss A; Trope GE;
    Can J Ophthalmol; 2012 Feb; 47(1):51-4. PubMed ID: 22333852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta-analysis of randomized controlled trials comparing selective laser trabeculoplasty with prostaglandin analogue in the primary treatment of open-angle glaucoma or ocular hypertention].
    Peng W; Zhong X; Yu M
    Zhonghua Yan Ke Za Zhi; 2014 May; 50(5):343-8. PubMed ID: 25052803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICare Pro: Age Dependent Effect of Central Corneal Thickness on Intraocular Pressure in Glaucoma and Ocular Hypertension Patients.
    Hohberger B; Sommerfeld C; Lucio M; Bergua A
    Curr Eye Res; 2020 Jun; 45(6):668-674. PubMed ID: 31905299
    [No Abstract]   [Full Text] [Related]  

  • 17. Combining corneal hysteresis with central corneal thickness and intraocular pressure for glaucoma risk assessment.
    Pensyl D; Sullivan-Mee M; Torres-Monte M; Halverson K; Qualls C
    Eye (Lond); 2012 Oct; 26(10):1349-56. PubMed ID: 22878449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma.
    Hu J; Vu JT; Hong B; Gottlieb C
    Br J Ophthalmol; 2020 Aug; 104(8):1040-1044. PubMed ID: 32532763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel Scheimpflug-based non-contact tonometer in healthy subjects and patients with ocular hypertension and glaucoma.
    Reznicek L; Muth D; Kampik A; Neubauer AS; Hirneiss C
    Br J Ophthalmol; 2013 Nov; 97(11):1410-4. PubMed ID: 23969314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central corneal thickness in primary open angle glaucoma, pseudoexfoliative glaucoma, ocular hypertension, and normal population.
    Yagci R; Eksioglu U; Midillioglu I; Yalvac I; Altiparmak E; Duman S
    Eur J Ophthalmol; 2005; 15(3):324-8. PubMed ID: 15944999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.